PYC
PYC THERAP FPO [PYC]
Healthcare · ASX Small Cap
$1.4950 -0.7%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +1First seen: 2026-02-25
Score Breakdown
Technical69
Catalyst58
Sentiment50
Fundamental34
Momentum57
Risk Gate50
Active Signals
Bullish Signals
- RSI approaching oversold
- MACD momentum strengthening
- Bollinger squeeze (breakout building)
- Volatility contracting (breakout setup)
- Above 200-day MA (long-term uptrend)
- Adequate cash runway (7 quarters)
- Very high P/S ratio (68.9x)
- Revenue in sharp decline (-25%)
- EPS estimates revised downward (-10pts)
- CANSLIM S: Tight float (39%)
- CANSLIM I: Institutional ownership (14%)
- Positive 12-1 momentum (+21%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Price below MAs (downtrend)
- Piotroski F-Score weak (3/9)
- Deeply negative margins (-231%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Revenue momentum declining (-25%)
Recent Catalysts
MEDIUM PKD Clinical Trial - Approval to Escalate Dosing
NONE Change in substantial holding
NONE 2026 Q1 Investor Update
NONE Half Yearly Report and Accounts
Recent ASX Announcements
| 2026-02-26 | PKD Clinical Trial - Approval to Escalate Dosing PRICE SENSITIVE |
| 2026-02-24 | Change in substantial holding |
| 2026-02-23 | 2026 Q1 Investor Update |
| 2026-02-23 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-02-17 | Application for quotation of securities - PYC |
Key Metrics
$1.4B
Market Cap
1.5M
Avg Volume
0.7x
Vol Ratio
$0.85 — $1.75
52-Week Range
0.4%
Short Interest
N/A
Cash Runway
-47.5%
ROE
-231.3%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 39% |
| L | Leader vs Laggard | laggard | RS: 0 |
| I | Institutional Sponsorship | pass | Inst: 14% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #46 of 119 · Sector avg: 51
View all Healthcare signals →